Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Company News

As of June 13, 2025 • 7:00 AM ET

Date/Time Source News Release
06/12/2025 08:30 AM EDT PR Newswire Volition Announces MARS Consortium Clinical Study Suggests Nu.Q® H3.1. Concentrations are Closely Associated with Sepsis and Organ Failure
06/04/2025 09:00 PM EDT PR Newswire Volition Announces Two Oral Presentations at Asian Meeting of Animal Medicine Specialties
05/19/2025 08:30 AM EDT PR Newswire VolitionRx Limited Announces Successful Detection of Nucleosomes in Cats
05/15/2025 05:37 PM EDT PR Newswire VolitionRx Limited Announces First Quarter 2025 Financial Results and Business Update
05/12/2025 08:30 AM EDT PR Newswire VolitionRx Limited Schedules First Quarter 2025 Earnings Conference Call and Business Update
05/07/2025 08:30 AM EDT PR Newswire VolitionRX Limited: Outlines broad strategy to become the 'NETs company' worldwide through licensing and updates progress of Nu.Q® NETs test adoption
04/29/2025 08:30 AM EDT PR Newswire VolitionRX Limited: Revolutionizing the diagnosis and monitoring of life-altering diseases for both humans and animals in multi-billion dollar markets
03/31/2025 04:05 PM EDT PR Newswire VolitionRx Limited Announces Full Fiscal Year 2024 Financial Results and Business Update
03/28/2025 08:00 AM EDT PR Newswire Volition Announces Two Poster Presentations at ESMO's European Lung Cancer Congress 2025
03/27/2025 08:30 AM EDT PR Newswire Volition to Host Virtual Investor Event on Nu.Q® Cancer, "A Look to the Future of Cancer Diagnostics", on April 9, 2025
Page

Additional News

As of June 13, 2025 • 7:00 AM ET

Date/Time Source News Release
05/16/2025 07:20 PM EDT SeekingAlpha VolitionRX aims for cash flow neutrality in 2025 as human diagnostics licensing advances
05/16/2025 07:19 PM EDT SeekingAlpha VolitionRX Limited (VNRX) Q1 2025 Earnings Call Transcript
05/16/2025 06:32 AM EDT SeekingAlpha VolitionRX GAAP EPS of -$0.06, revenue of $0.25M
05/15/2025 10:41 AM EDT SeekingAlpha VolitionRX Q1 2025 Earnings Preview
04/01/2025 12:31 AM EDT SeekingAlpha VolitionRx outlines 2025 licensing goals and targets cash neutrality with strategic expansions
04/01/2025 12:31 AM EDT SeekingAlpha VolitionRx Limited (VNRX) Q4 2024 Earnings Call Transcript
03/31/2025 04:22 PM EDT SeekingAlpha VolitionRX reports FY results
12/06/2024 09:58 AM EST SeekingAlpha VolitionRx announces pricing of up to $1.9M registered direct offering
11/15/2024 11:47 AM EST SeekingAlpha VolitionRx Limited (VNRX) Q3 2024 Earnings Call Transcript
11/14/2024 04:18 PM EST SeekingAlpha VolitionRX reports Q3 results
Page

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.